TH156762A - Inhibition of IL 17 and IFN-gamma for the treatment of autoimmune inflammation. - Google Patents
Inhibition of IL 17 and IFN-gamma for the treatment of autoimmune inflammation.Info
- Publication number
- TH156762A TH156762A TH1301004188A TH1301004188A TH156762A TH 156762 A TH156762 A TH 156762A TH 1301004188 A TH1301004188 A TH 1301004188A TH 1301004188 A TH1301004188 A TH 1301004188A TH 156762 A TH156762 A TH 156762A
- Authority
- TH
- Thailand
- Prior art keywords
- general formula
- inflammatory
- invention involves
- acceptable salts
- pharmacologically acceptable
- Prior art date
Links
- 102100016020 IFNG Human genes 0.000 title 1
- 101700086956 IFNG Proteins 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 title 1
- 230000001363 autoimmune Effects 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 239000000126 substance Substances 0.000 claims abstract 7
- 150000001875 compounds Chemical class 0.000 claims abstract 5
- 150000003839 salts Chemical class 0.000 claims abstract 5
- 239000011780 sodium chloride Substances 0.000 claims abstract 5
- 230000003110 anti-inflammatory Effects 0.000 claims abstract 4
- 239000003795 chemical substances by application Substances 0.000 claims abstract 4
- 239000003814 drug Substances 0.000 claims abstract 4
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 230000002519 immonomodulatory Effects 0.000 claims abstract 2
- 230000000051 modifying Effects 0.000 claims abstract 2
- 239000012453 solvate Substances 0.000 claims abstract 2
- -1 acryl Chemical group 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
Abstract
DC60 (17/10/56) การประดิษฐ์นี้เกี่ยวข้องกับสารประกอบของสูตรทั่วไป (I) เเละเกลือหรือโซลเวทที่ยอมรับในทาง เภสัชกรรมของสารนี้เป็นสารต้านการอักเสบเเละสารปรับเปลี่ยนภูมิคุ้มกัน (สูตรเคมี) สูตร (I) การประดิษฐ์นี้เกี่ยวข้องกับสารประกอบที่มีสูตรทั่วไป(I)เเละเกลือที่ยอมรับได้ทางเภสัชกรรม หรือโซเวตของสารเหล่านั้น ดังที่เป็นเอเจนต์ต้านการอักเสบเเละการปรับระบบภูมิคุ้มกัน (immunmodulati=ory) สิทธิบัตรยา DC60 (17/10/56) This invention involves a compound of the general formula (I) and a salt or solvate that is well accepted. The pharmaceuticals of this substance are anti-inflammatory and immune modifying agents (chemical formulas), formula (I). The invention involves compounds with a general formula (I) and pharmacologically acceptable salts. Or the sovate of those substances As an anti-inflammatory and immune modulating agent (immunmodulati = ory) drug patent
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH156762A true TH156762A (en) | 2016-09-26 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112016011755A2 (en) | derived from urea or pharmacologically acceptable salt thereof | |
| CL2012001641A1 (en) | Piperazine derived compounds; pharmaceutical composition; comprising one of the compounds and use of the compounds in the preparation of medicaments for the treatment and / or prevention of protozoal infections, in particular for the treatment and / or prevention of malaria. | |
| TH156762A (en) | Inhibition of IL 17 and IFN-gamma for the treatment of autoimmune inflammation. | |
| EA201300160A1 (en) | 2,3,5-Trisulfonated TIOPHENES AND THEIR APPLICATION | |
| TH153138A (en) | Inhibition of IL 17 and IFN-gamma for the treatment of anti-immune inflammation. | |
| TH1601004492A (en) | New tetrahydropyridopyrimidine compounds or their salts | |
| TH169353A (en) | Acetidinyl oxychophenyl perrolidine compound | |
| TH170295A (en) | Tetracyclic bromo-domain inhibitors | |
| TH1501005211A (en) | Elements for the treatment of sleep apnea | |
| TH146336A (en) | Pyridazinone compounds and their use as DAAO inhibitors | |
| TH135739A (en) | SMAC impurities | |
| TH129189A (en) | N1-pyrazolose pyrocytone inhibitors Acetyl-COA carboxylase | |
| TH167426A (en) | Hetero-aeryl or bicyclic-bonded aryl compounds and their use That substance as an IRAK4 inhibitor | |
| TH169297A (en) | Derivatives of dolastatin 10 and auristatins | |
| TH181689A (en) | 4-oxo-3,4-dihydro-1,2,3-benzotriacine used as a modifying agent for GPR139. | |
| TH158502A (en) | Heterocyclic compounds | |
| TH154970A (en) | Aca indolene | |
| TH121183A (en) | Methods and agents for pharmaceutical preparation | |
| TH169423A (en) | Tetrahydroimmidazo derivatives [1,5-d] [1,4] oxacipine | |
| TH157676A (en) | Pyrazole compounds as SGLT1 inhibitors | |
| TH146331A (en) | Inda Seoul | |
| TH153195A (en) | Neprilisin inhibitor | |
| TH182678A (en) | Tetrahydroquinoline derivatives, bromodomain inhibitors | |
| TH176362A (en) | "Compound pharmaceutical elements And using it in therapy Degenerative diseases of the nervous system " | |
| TH1501003494A (en) | PRMT5 inhibitors and their use |